National Cancer Institute; Notice of Closed Meeting, 29297 [2017-13466]
Download as PDF
asabaliauskas on DSKBBXCHB2PROD with NOTICES
Federal Register / Vol. 82, No. 123 / Wednesday, June 28, 2017 / Notices
foundational principles. Every 10 years,
through the Healthy People initiative,
HHS leverages scientific insights and
lessons from the past decade along with
new knowledge of current data, trends,
and innovations to develop the next
iteration of national health promotion
and disease prevention objectives.
Healthy People provides science-based,
10-year national objectives for
promoting health and preventing
disease. Since 1979, Healthy People has
set and monitored national health
objectives to meet a broad range of
health needs, encouraged collaborations
across sectors, guided individuals
toward making informed health
decisions, and measured the impact of
our prevention and health promotion
activities. Healthy People 2030 will
reflect assessments of major risks to
health and wellness, changing public
health priorities, new knowledge in
prevention, and emerging issues related
to our nation’s health preparedness.
DATES: In order for comments on the
proposed vision, mission, overarching
goals, and framework for Healthy People
2030 to be considered, written
comments must be submitted via the
Internet at www.HealthyPeople.gov by
5:00 p.m. Eastern Time on September
29, 2017.
ADDRESSES: The proposed framework
for Healthy People 2030 can be viewed
and commented upon at https://
www.healthypeople.gov.
FOR FURTHER INFORMATION CONTACT:
Ayanna Johnson, Public Health Advisor,
U.S. Department of Health and Human
Services, Office of the Assistant
Secretary for Health, Office of Disease
Prevention and Health Promotion, 1101
Wootton Parkway, Suite LL100,
Rockville, MD 20852, HP2030@hhs.gov
(email), or (240) 245–8281 (fax).
SUPPLEMENTARY INFORMATION:
Background: The Healthy People
development process strives to
maximize transparency, public input
and stakeholder dialogue to ensure that
Healthy People 2030 is relevant to
diverse public health needs and seizes
opportunities to achieve its goals. Since
its inception, Healthy People has
become a broad-based, public
engagement initiative with thousands of
citizens helping to shape it at every step
along the way. Drawing on the expertise
of a Secretary’s Advisory Committee on
National Health Promotion and Disease
Prevention Objectives for 2030 and
public input, Healthy People will be
organized to establish a framework to
address risk factors and determinants of
health and the diseases and disorders
that are affecting our communities.
Public participation will shape Healthy
VerDate Sep<11>2014
17:22 Jun 27, 2017
Jkt 241001
People 2030, its purpose, goals,
organization, and action plans. HHS is
soliciting written public comments on
the development of Healthy People 2030
through online public comment. As a
national initiative, Healthy People’s
success depends on a coordinated
commitment to improve the health of
the nation. Individuals may subscribe to
the listserv at: https://bit.ly/2g3tqdE for
the latest information on Healthy People
2020 and Healthy People 2030.
Authority: 42 U.S.C. 200u.
Dated: June 1, 2017.
Don Wright,
Deputy Assistant Secretary for Health,
Disease Prevention and Health Promotion.
[FR Doc. 2017–13463 Filed 6–27–17; 8:45 am]
29297
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: June 22, 2017.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–13466 Filed 6–27–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4150–32–P
National Institutes of Health
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Office of the Director; Notice of
Meeting
National Institutes of Health
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the NIH
Clinical Center Research Hospital
Board.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The portion of the meeting devoted to
the identification and evaluation of
specific candidates for consideration for
a leadership position in the Clinical
Center will be closed to the public in
accordance with the provisions set forth
in section 552b(c)(9)(B) and 552b(c)(6),
Title 5 U.S.C., as amended. Premature
disclosure of potential candidates and
their qualifications, as well as the
discussions by the committee, could
significantly frustrate NIH’s ability to
recruit these individuals and the
consideration of personnel
qualifications, performance, and the
competence of individuals as candidates
would constitute a clearly unwarranted
invasion of personal privacy.
National Cancer Institute; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
Frederick National Laboratory Advisory
Committee to the National Cancer
Institute.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The discussion of research
projects/programs could disclose
unpublished and financial data,
technical information, confidential trade
secrets or commercial property, such as
patentable material, and personal
information concerning investigators/
individuals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Frederick National
Laboratory Advisory Committee to the
National Cancer Institute.
Date: July 18, 2017.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review the existing research
portfolio (both intramural and extramural)
and newly initiated research projects being
conducted at the Frederick National
Laboratory for Cancer Research (FNLCR).
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
TE406, Rockville, MD 20850 (Virtual
Meeting).
Contact Person: Caron A. Lyman, Ph.D.,
Executive Secretary, National Cancer
Institute, National Institutes of Health, 9609
Medical Center Drive, Room 7W–126,
Bethesda, MD 20892, 240–276–6348,
lymanc@mail.nih.gov.
PO 00000
Frm 00024
Fmt 4703
Sfmt 4703
Name of Committee: NIH Clinical Center
Research Hospital Board.
Date: July 14, 2017.
Open: 9:00 a.m. to 3:15 p.m.
Agenda: Clinical Protocol Prioritization;
Patient Safety Tracking; AAHRP 5 Year
Accreditation Process; Bioethics; Report on
CC Focus Groups.
Place: National Institutes of Health,
Building 31, 6th Floor, Conference Room
6C6, 31 Center Drive, Bethesda, MD 20892.
Closed: 3:30 p.m. to 5:00 p.m.
E:\FR\FM\28JNN1.SGM
28JNN1
Agencies
[Federal Register Volume 82, Number 123 (Wednesday, June 28, 2017)]
[Notices]
[Page 29297]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-13466]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of a meeting of the
Frederick National Laboratory Advisory Committee to the National Cancer
Institute.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The discussion of research projects/programs could
disclose unpublished and financial data, technical information,
confidential trade secrets or commercial property, such as patentable
material, and personal information concerning investigators/
individuals, the disclosure of which would constitute a clearly
unwarranted invasion of personal privacy.
Name of Committee: Frederick National Laboratory Advisory
Committee to the National Cancer Institute.
Date: July 18, 2017.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review the existing research portfolio (both
intramural and extramural) and newly initiated research projects
being conducted at the Frederick National Laboratory for Cancer
Research (FNLCR).
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room TE406, Rockville, MD 20850 (Virtual Meeting).
Contact Person: Caron A. Lyman, Ph.D., Executive Secretary,
National Cancer Institute, National Institutes of Health, 9609
Medical Center Drive, Room 7W-126, Bethesda, MD 20892, 240-276-6348,
lymanc@mail.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: June 22, 2017.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-13466 Filed 6-27-17; 8:45 am]
BILLING CODE 4140-01-P